Home › Funds › Merck & Co., Inc. › PSNL

Merck & Co., Inc. position in PSNL

PERSONALIS INC · Health Care

Merck & Co., Inc. reported holding 14,044,943 shares of PSNL (PERSONALIS INC) in its Q3 2026 13F filing — a position valued at US$228.7M, representing 27.87% of its reported portfolio and ranking #2 among its reported holdings. Merck & Co., Inc. has disclosed PSNL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)14.04M sh
Reported value held$228.65M
Portfolio Weight27.87%
First reportedQ4 2024
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Merck & Co., Inc.'s PSNL position evolved

Merck & Co., Inc. first disclosed a stake in PSNL in Q4 2024 at 14,044,943 shares (US$81.2M). The position peaked in Q3 2026 at 14,044,943 shares, worth US$228.7M. Across 8 filings, Merck & Co., Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 14,044,943 shares valued at US$228.7M.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 14.04M $81.18M New
Q1 2025 14.04M $49.30M Hold
Q2 2025 14.04M $92.13M Hold
Q3 2025 14.04M $91.57M Hold
Q4 2025 14.04M $111.80M Hold
Q1 2026 14.04M $89.47M Hold
Q2 2026 14.04M $188.20M Hold
Q3 2026 14.04M $228.65M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PSNL and 13F data

PSNL (PERSONALIS INC) is a Health Care company. 56 other funds we track also report a position in PSNL — the largest reported positions include ARK Invest (US$115.9M), Lightspeed Management Company, L.L.C. (US$99.3M), Deep Track Capital, LP (US$53.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PSNL

All PSNL fund holders →

FAQ

How long has Merck & Co., Inc. held PSNL?

Merck & Co., Inc. has disclosed PSNL holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Merck & Co., Inc.'s current position in PSNL?

As of Q3 2026, Merck & Co., Inc. holds 14.04M shares of PSNL (PERSONALIS INC), valued at $228.65M, representing 27.87% of its reported portfolio and ranking #2.

Has Merck & Co., Inc. been buying or selling PSNL?

In the latest 13F filing (Q3 2026), Merck & Co., Inc. held unchanged its position in PSNL. The position peaked in Q3 2026 at 14.04M shares.

Which other funds hold PSNL?

Other major institutional holders of PSNL include ARK Invest, Lightspeed Management Company, L.L.C., Deep Track Capital, LP, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.